A phase I study of combined docetaxel and repeated high activity 186Re-HEDP in castration-resistant prostate cancer (CRPC) metastatic to bone (the TAXIUM trial)
2011 ◽
Vol 38
(11)
◽
pp. 1990-1998
◽
Keyword(s):
Phase I
◽
2018 ◽
Vol 24
(21)
◽
pp. 5225-5232
◽
2009 ◽
2010 ◽
Vol 28
(15_suppl)
◽
pp. e13563-e13563